dealase

Biotech · Public company · New York, NY, US

In8bio, Inc.

Ticker INAB · SEC CIK 0001740279

Track this companyFree. Adds In8bio, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed

Pipeline2

Clinical trials2

  • A Phase 1b / 2 Drug Resistant Immunotherapy With Activated, Gene Modified Allogeneic or Autologous γδ T Cells (DeltEx) in Combination With Maintenance Temozolomide in Subjects With Recurrent or Newly Diagnosed GlioblastomaPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Sep 8, 2023ClinicalTrials.gov NCT05664243 · fetched Nov 12, 2026
  • Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant CyclophosphamidePHASE1 · RECRUITING · started Jan 31, 2020ClinicalTrials.gov NCT03533816 · fetched Nov 12, 2026

SEC filings12